Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avangrid, Inc. stock logo
AGR
Avangrid
$36.84
-0.6%
$34.42
$27.46
$41.22
$14.25B0.56923,254 shs813,912 shs
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
$7.27
+1.0%
$7.39
$6.25
$8.84
N/A1.131.46 million shs687,296 shs
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
$14.10
$0.00
$11.77
$14.35
N/AN/A24,907 shsN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%
C$0.26
C$0.15
C$0.53
C$52.28MN/A644,760 shs384,329 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avangrid, Inc. stock logo
AGR
Avangrid
+0.49%+3.09%+3.46%+19.71%-9.24%
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
0.00%-7.47%-2.45%0.00%-6.02%
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
0.00%0.00%0.00%0.00%0.00%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avangrid, Inc. stock logo
AGR
Avangrid
4.0691 of 5 stars
0.95.02.52.72.21.73.1
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/AN/AN/AN/AN/AN/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avangrid, Inc. stock logo
AGR
Avangrid
1.75
Reduce$34.75-5.67% Downside
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/AN/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Latest COB, MGL, CLM, AGR, and EMH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/8/2024
Avangrid, Inc. stock logo
AGR
Avangrid
Janney Montgomery Scott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Sell$35.00
2/23/2024
Avangrid, Inc. stock logo
AGR
Avangrid
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$34.00 ➝ $35.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avangrid, Inc. stock logo
AGR
Avangrid
$8.31B1.71$5.08 per share7.25$53.46 per share0.69
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/AN/AN/AN/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avangrid, Inc. stock logo
AGR
Avangrid
$786M$2.0318.1515.222.769.46%3.92%1.90%4/23/2024 (Confirmed)
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/A0.00N/AN/AN/AN/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/A0.00N/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/AN/AN/AN/AN/AN/A

Latest COB, MGL, CLM, AGR, and EMH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2024N/A
Avangrid, Inc. stock logo
AGR
Avangrid
$0.70$0.68-$0.02N/AN/AN/A  
2/22/2024Q4 2023
Avangrid, Inc. stock logo
AGR
Avangrid
$0.94$0.97+$0.03$0.91$2.40 billion$2.28 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avangrid, Inc. stock logo
AGR
Avangrid
$1.764.78%N/A86.70%N/A
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
$1.4219.53%-12.82%N/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A

Latest COB, MGL, CLM, AGR, and EMH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
Avangrid, Inc. stock logo
AGR
Avangrid
quarterly$0.444.9%5/31/20246/3/20247/1/2024
2/14/2024
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
monthly$0.108618.3%6/14/20246/14/20246/28/2024
2/12/2024
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
monthly$0.108618.3%5/14/20245/15/20245/31/2024
2/12/2024
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
monthly$0.108618.1%4/12/20244/15/20244/30/2024
2/15/2024
Avangrid, Inc. stock logo
AGR
Avangrid
quarterly$0.445.6%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avangrid, Inc. stock logo
AGR
Avangrid
0.48
0.65
0.56
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/AN/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avangrid, Inc. stock logo
AGR
Avangrid
13.12%
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/A
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
65.78%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avangrid, Inc. stock logo
AGR
Avangrid
7,999386.78 million386.55 millionOptionable
Cornerstone Strategic Value Fund, Inc. stock logo
CLM
Cornerstone Strategic Value Fund
N/AN/AN/ANot Optionable
CommunityOne Bancorp stock logo
COB
CommunityOne Bancorp
N/AN/AN/ANot Optionable
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable

COB, MGL, CLM, AGR, and EMH Headlines

SourceHeadline
University Hospitals Elyria Medical CenterUniversity Hospitals Elyria Medical Center
health.usnews.com - September 23 at 12:26 AM
Digital Therapeutics: Next wave in managing chronic medical conditionsDigital Therapeutics: Next wave in managing chronic medical conditions
health.economictimes.indiatimes.com - September 13 at 9:19 PM
The Digital Therapeutics Market Is GangbustersThe Digital Therapeutics Market Is Gangbusters
mddionline.com - August 29 at 11:45 PM
Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Study
finance.yahoo.com - July 31 at 12:17 AM
Emerald Isle’s Lee Avenue to close again soon as culvert project restartsEmerald Isle’s Lee Avenue to close again soon as culvert project restarts
carolinacoastonline.com - July 15 at 8:44 AM
Efficient Market Hypothesis (EMH): Definition and CritiqueEfficient Market Hypothesis (EMH): Definition and Critique
investopedia.com - July 12 at 2:56 PM
Revolutionizing mental health treatment: Vistagen Therapeutics nasal spray solutionRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution
finance.yahoo.com - June 20 at 12:36 PM
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
thaipr.net - May 29 at 4:23 AM
Emerald Care Center TulsaEmerald Care Center Tulsa
health.usnews.com - May 4 at 11:26 PM
Emerald ReegEmerald Reeg
health.usnews.com - April 25 at 7:35 AM
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6MEmerald Expositions GAAP EPS of $0.06, revenue of $93.6M
msn.com - March 14 at 9:07 AM
Tahoes Emerald Bay freezes over for first time in decades amid atmospheric riverTahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
sfgate.com - March 13 at 4:02 AM
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
venturebeat.com - March 4 at 6:25 PM
Emerald community raising money for local dialysis services after political campaigns failEmerald community raising money for local dialysis services after political campaigns fail
abc.net.au - February 25 at 12:07 AM
New Digital Therapeutics Company Takes a Swing at FibromyalgiaNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgia
mddionline.com - February 22 at 11:25 PM
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
finance.yahoo.com - January 14 at 1:43 PM
Emerald Health Therapeutics Inc (TBD.BE)Emerald Health Therapeutics Inc (TBD.BE)
finance.yahoo.com - January 4 at 3:42 AM
Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderEmerald Health Therapeutics Announces Revocation of Management Cease Trade Order
finance.yahoo.com - July 12 at 9:36 AM
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate UpdateEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
finance.dailyherald.com - July 4 at 7:56 AM
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
finance.yahoo.com - June 16 at 8:02 AM
Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
stockhouse.com - May 16 at 4:37 PM
Skye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
nz.finance.yahoo.com - May 12 at 9:26 AM
Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQB
investorideas.com - May 6 at 10:47 AM
Emperor Oil Ltd (EMh)Emperor Oil Ltd (EMh)
investing.com - January 5 at 8:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avangrid logo

Avangrid

NYSE:AGR
Avangrid, Inc., an energy services holding company, engages in the regulated energy transmission and distribution, and renewable energy generation businesses in the United States. The company operates through Networks and Renewables segments. It is involved in the generation, transmission, and distribution of electricity; and distribution, transportation, and sale of natural gas. In addition, the company operates renewable energy generation facilities primarily using onshore wind power, as well as solar, biomass, and thermal power. Further, it delivers natural gas and electricity to residential, commercial, and institutional customers through its regulated utilities in New York, Maine, Connecticut, and Massachusetts; and sells its output to investor-owned utilities, public utilities, and other credit-worthy entities, as well as generates and provides power and other services to federal and state agencies, institutional retail, and joint action agencies. Additionally, the company delivers thermal output to wholesale customers in the Western United States. It owns eight electric and natural gas utilities, serving 3.3 million customers in New York and New England, as well as owns and operates 9.3 gigawatts of electricity capacity primarily through wind power in 22 states. Avangrid, Inc. was incorporated in 1997 and is headquartered in Orange, Connecticut. The company operates as a subsidiary of Iberdrola, S.A.
Cornerstone Strategic Value Fund logo

Cornerstone Strategic Value Fund

NYSEAMERICAN:CLM
Cornerstone Strategic Value Fund, Inc. is a closed-ended equity mutual fund launched and managed by Cornerstone Advisors, LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value and growth stocks of companies. It also invests through other closed-end investment companies and ETF's. Cornerstone Strategic Value Fund, Inc. was formed on May 1, 1987 and is domiciled in the United States.
CommunityOne Bancorp logo

CommunityOne Bancorp

NASDAQ:COB
CommunityOne Bancorp (COB) is a bank holding company. The Company, through the ownership of CommunityOne Bank, N.A., or the Bank, a national banking association, offers consumer, mortgage and business banking services, including loan, deposit, treasury management, online and mobile banking services, as well as wealth management and trust services, to individual, and small and middle market businesses through financial centers located across central, southern and western North Carolina. The Bank operates over 40 branches. In addition to the Bank, the Company owns FNB United Statutory Trust I, FNB United Statutory Trust II, and Catawba Valley Capital Trust II, which were formed to facilitate the issuance of trust preferred securities. The Bank's loans totaled approximately $1.54 billion. The Bank's total investment securities totaled approximately $546.782 million. The Bank's deposits totaled approximately $1.95 billion.
Emerald Health Therapeutics logo

Emerald Health Therapeutics

CVE:EMH
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.